专业、权威、深度，Since1990。 导语：行业竞 争正从"流量博弈"转向"技术比拼"。 以下文章来源于化妆品报 ，作者钱莹 化妆品报 . 据化妆品报不完全统计，2025上半年，国内外化妆品头部企业至少有近30起重要人事变动。 除此之外，珀莱雅和上海家化两家，副总经理的职位也处于空缺。 | रहे बाद कि बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में कि की है कि की है कि कि की है कि कि की है | 职务 | 继任人 | 原职/曾就职经历 | | --- | --- | --- | --- | | 贝泰妮 | 副总经理 | 吴小静 | 上海威亮COO | | 珀莱雅 | 副总经理 | 暂时空缺 | | | | 首席研发创新官 | 孙培文 | PMPM母公司时垠集团 CSO (首席科研官) | | | 直席科学官 | 黄虎 | 上美股份CTO兼全球首席科学家 | | | CD ...

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, highlighting innovative business models driving growth in the light medical beauty sector, particularly recommending attention to the company "Xinyang" [2][9]. Core Insights - The cosmetics and medical beauty sector has underperformed the market recently, with the Shenwan Beauty Care Index declining by 0.1% from July 11 to July 18, 2025, while the Shenwan Cosmetics Index fell by 0.9%, underperforming the Shenwan A Index by 2.3 percentage points [3][4]. - Innovative business models are driving growth in light medical beauty, contrasting with traditional medical beauty institutions facing stagnation due to high costs and weak consumer demand. Xinyang's high cost-performance ratio, chain operations, and app-based customer conversion model are seen as new growth drivers for the sector [9][10]. - The report emphasizes the importance of supply-side innovations in stimulating consumer demand and driving industry recovery, despite short-term macroeconomic challenges [9]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown weak performance compared to the market, with specific indices reflecting declines during the reporting period [3][4]. - The top-performing stocks in the sector included Zhongshun Jierou (+10.8%) and Juzibio (+6.1%), while the worst performers were Shangmei Shares (-11.1%) and Baiya Shares (-4.3%) [5]. Key Company Insights - Linqingxuan, a high-end domestic skincare brand, has seen revenue growth from 690 million yuan in 2022 to 1.21 billion yuan in 2024, with net profit turning from a loss of 6 million yuan to a profit of 187 million yuan [10][15]. - The company has established a strong product matrix and supply chain advantages, with production capacity reaching 40 million units annually [16][17]. - The report also highlights the growth of the "Plant Doctor" brand, which has achieved a net profit CAGR of 24% from 2022 to 2024, supported by a robust channel network and operational efficiencies [10][12]. Market Trends - The report notes a shift in the cosmetics market from quantity to quality, with a significant increase in e-commerce sales, which accounted for 47% of total cosmetics sales in 2024, up from 22% in 2016 [11]. - The domestic market is witnessing a rise in local brands, with a notable increase in market share for domestic products, reflecting changing consumer preferences and the impact of the "national tide" [11][28]. Financial Performance - The report indicates that the overall retail sales of cosmetics in China reached 229.1 billion yuan in the first half of 2025, with a year-on-year growth of 2.9%, although June saw a decline of 2.3% due to promotional timing [21][24]. - The performance of major companies like Meili Tianyuan is highlighted, with projected revenue of at least 1.45 billion yuan for the first half of 2025, representing a growth of at least 27% [24].

Group 1 - The core viewpoint of the article highlights the recognition of Beitaini Group as a leading brand in the international market, particularly through its inclusion in the "Top 100 Chinese Brands for Internationalization" list, showcasing its global influence and innovative capabilities [1][2] - The conference aimed to decode the successful path of Chinese brand internationalization, focusing on innovation, leadership, and brand value, thereby establishing a new image for Chinese brands on the global stage [1] - Beitaini Group has established research and development centers in Shanghai and Kunming, as well as advanced laboratories in Paris and Tokyo, to enhance international R&D collaboration [1] Group 2 - The company is set to launch its Southeast Asia headquarters in Bangkok in early 2024, further solidifying its global operational footprint [1] - Beitaini Group leverages its strong R&D capabilities and unique plant resources from Yunnan to market advanced skincare technologies, including sensitive skin and anti-aging products [1] - The core brand Winona has been recognized in the first batch of China's consumer brand list published by the Ministry of Industry and Information Technology, reflecting its brand value and market position [2]

Investment Rating - The report maintains a positive outlook on the cosmetics and medical beauty industry, indicating a "Buy" recommendation for several companies within the sector [2][14]. Core Insights - The cosmetics and medical beauty sector has shown weaker performance compared to the market, with the Shenwan Beauty Care Index rising by 1.5% from July 4 to July 11, 2025, which is below the market average [3][5]. - The introduction of new products in the regenerative medicine sector, particularly in the "童颜针" (youthful needle) category, is expected to enhance consumer interest and expand the market [2][8]. - The report highlights strong anticipated earnings growth for several key companies in the cosmetics sector for the second quarter of 2025, with notable increases in revenue and net profit for brands like 上美股份 (Shangmei), 丸美股份 (Marubi), and 珀莱雅 (Proya) [9][10][11]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has underperformed the market, with specific indices showing varied performance, such as the Shenwan Cosmetics Index increasing by 2.6% [3][5]. - The report notes that the demand for cosmetics is recovering, with a 4.1% year-on-year increase in retail sales for the first five months of 2025 [19][20]. Company Performance - 上美股份 (Shangmei) is expected to see a revenue increase of 16% and a net profit increase of 25% in the first half of 2025 [10]. - 丸美股份 (Marubi) anticipates a 22% revenue growth and a 28% increase in net profit for the second quarter of 2025 [10]. - 珀莱雅 (Proya) is projected to achieve a 10% revenue growth and a 15% increase in net profit for the second quarter of 2025 [10]. - 毛戈平 (Mao Geping) expects a significant revenue increase of 38% and a net profit increase of 35% in the first half of 2025 [10]. - 若羽臣 (Ruoyuchen) forecasts a remarkable 70% revenue growth and a 75% increase in net profit for the second quarter of 2025 [10]. Market Trends - The report emphasizes the ongoing trend of domestic brands gaining market share, with national brands occupying five of the top ten positions in the skincare market [32]. - The regenerative medicine sector is expanding, with new products enhancing consumer engagement and market growth potential [2][8]. Investment Recommendations - The report recommends focusing on companies with strong brand matrices and high growth potential, such as 上美股份 (Shangmei), 珀莱雅 (Proya), and 丸美股份 (Marubi) [14]. - It suggests monitoring companies that leverage e-commerce and social media platforms effectively, such as 若羽臣 (Ruoyuchen) and 毛戈平 (Mao Geping) [14].

Core Insights - The article highlights Betaini's leadership in the sustainable skincare industry in China, showcasing its strong ESG practices and recognition from authoritative rating agencies [1][3][4]. ESG Ratings and Recognition - Betaini received the highest "AAA" rating from Huazheng ESG and "AA" certification from Wind ESG, demonstrating its leading position in the consumer sector [3][4]. - In the 2025 Huazheng A-share ESG Excellence TOP 100 list, Betaini was included, reflecting its commitment to integrating ESG into its core strategy [1]. Environmental Initiatives - The new central factory, covering 80 acres and costing nearly 500 million, has an annual output value of 5 billion, utilizing low-carbon materials and solar energy [6]. - Betaini's packaging innovation includes a plan to recycle nearly 2.67 million empty bottles in 2024 and aims for 93% of new products to use FSC-certified paper by 2025 [7]. - The company has invested in carbon management, with a rooftop solar project generating approximately 875,000 kWh of electricity, reducing CO2 emissions by 1.18 million kg annually [9]. Biodiversity and Community Engagement - Betaini's public welfare fund has invested 3.13 million in biodiversity protection, including ecological restoration projects in Haba Snow Mountain [10]. - The company supports local education through initiatives like the "Betaini Hope Primary School" and scholarships for students [14]. Innovation and R&D - Betaini focuses on skin health and has been recognized as a "National Industrial Design Center" and "National Technology Innovation Demonstration Enterprise" [12]. - The company has developed 241 new products, contributing an additional 11.304 billion in industry value [13]. Governance and Compliance - Betaini has established a comprehensive ESG governance structure, ensuring sustainable development is integrated into management and operations [18]. - The company conducts regular audits and compliance checks to manage ESG-related risks effectively [19][20]. Future Goals - Betaini aims to deepen its ESG practices, enhance resource efficiency, and expand biodiversity projects while improving governance structures [26][23].

Core Insights - The article discusses recent developments in the nutrition and health industry, highlighting regulatory changes, new product approvals, and market trends that could impact investment opportunities [2][3][4][5][6]. Regulatory Developments - The State Administration for Market Regulation issued a guideline clarifying the definition of commercial advertising under the Advertising Law, addressing ongoing disputes in advertising enforcement [2]. - The National Health Commission approved D-alloheptulose and four other substances as new food raw materials, indicating a push for innovation in the nutrition sector [3]. - The market regulator released multiple responses to proposals regarding health food regulations, signaling a focus on traditional Chinese medicine formulations as a potential growth area [4]. Market Trends and Investment Opportunities - Yangtuo Technology Inc. submitted an IPO application to the Hong Kong Stock Exchange, aiming to raise funds for market expansion and supply chain optimization, reflecting growing investor interest in the nutrition and health sector [5]. - A report on 68 nutrition and health companies showed an average market value increase of 20% in the first half of the year, driven by rising consumer health awareness and demand for nutritional products [6]. Company Performance - New Hope Liuhe (002001) projected a net profit of 3.3 billion to 3.75 billion yuan for the first half of 2025, representing a year-on-year growth of 50% to 70% [12]. - Brother Technology (002562) expects a net profit of 60 million to 75 million yuan for the same period, marking an increase of 325% to 431% compared to the previous year [13]. New Product Launches - Guangji Pharmaceutical (000952) received a notice of administrative penalty for information disclosure violations, indicating regulatory scrutiny in the sector [14]. - TCM brand Tongrentang launched its first OTC glucosamine product, expanding its product line in the bone and joint health category [14].

Investment Rating - The report rates the cosmetics and medical beauty industry as "Positive" [2][3] Core Viewpoints - The cosmetics retail sales growth for January to May 2025 is 4.1%, an increase of 2 percentage points compared to the same period last year, indicating a steady recovery in demand [3] - The performance of leading brands remains strong, with double-digit growth, supported by the theme of self-care in new consumption trends, leading to a positive outlook for the first half of 2025 [3] - The 618 shopping festival saw strong performances from domestic brands, with notable rankings on platforms like Tmall and Douyin [3] Summary by Sections Cosmetics Industry Outlook - The report anticipates significant revenue and net profit growth for major companies in Q2 and H1 2025, with specific forecasts: - Up Beauty Co. is expected to see a revenue increase of 16% and a net profit increase of 25% [3] - Marubi is projected to grow revenue by 22% and net profit by 28% in Q2 2025 [3] - Proya is expected to achieve a revenue growth of 10% and net profit growth of 15% in Q2 2025 [3] Key Companies Performance - Notable companies and their expected performance include: - Mao Geping is projected to have a revenue increase of 38% and net profit increase of 35% in H1 2025 [3] - Ruibin is expected to see a revenue increase of 15% and net profit increase of 15% in Q2 2025 [3] - Huaxi Biological is expected to maintain stable performance with a 0% revenue growth and a 10% net profit increase in Q2 2025 [3] Investment Recommendations - The report recommends focusing on companies with strong brand matrices and comprehensive product layouts, such as Up Beauty Co., Marubi, and Proya, which are expected to benefit from the live e-commerce traffic [3] - It also highlights the importance of niche market players like Ruibin and Mao Geping, who are positioned to capitalize on the rise of personal care and domestic beauty trends [3] - For the medical beauty sector, the report suggests focusing on companies with high R&D barriers and strong profitability, recommending companies like Aimeike and Langzi [3] E-commerce and Other Segments - The report suggests monitoring e-commerce companies like Ruibin, which is expected to see significant growth in revenue and net profit [3] - In the maternal and infant sector, Kid King is projected to exceed market expectations with a revenue increase of 10% and a net profit increase of 70% in Q2 2025 [3]

投资者关系活动记录表 编号：2025-005 证券代码：300957 证券简称：贝泰妮 云南贝泰妮生物科技集团股份有限公司 | 投 资 者 关 系 活 | □特定对象调研 分析师会议 | | --- | --- | | 动类别 | □媒体采访 □业绩说明会 | | | □新闻发布会 路演活动 | | | 现场参观 | | | □其他 | | 参与单位名称 | Morgan Stanley、Goldman Sachs、贝莱德基金、瑞银资管、 | | | 富国基金、嘉实基金、中金基金、博时基金、工银安盛资管、 | | | 淡水泉（北京）投资管理有限公司、银华基金、长信基金、天 | | | 弘基金、新华基金、汇丰晋信基金、中信建投基金、泰康资 | | | 产、华宝基金、招商基金等 120 家机构 | | 时间 | 2025 年 6 月 | | 地点 | 线上、线下交流 | | 上 市 公 司 接 待 | 1、副总经理、财务总监、董事会秘书王龙 | | 人员姓名 | 2、投资者关系负责人张圣烨 | | | 3、IR 王广熙 | | | Q:公司近期在原料备案上有什么进展？ | | --- | --- | | | ...

Core Viewpoint - The demand for dermatological skincare products in China is rapidly increasing due to rising consumer health awareness and income levels, with the market expected to reach 22.528 billion yuan in 2024, reflecting a year-on-year growth of 21.13% [1][12]. Overview - Dermatological skincare products are developed based on dermatology and skin structure, aimed at addressing specific skin issues. They are characterized by simplified ingredients, higher safety, and clearer efficacy compared to regular skincare products [2][3]. Market Policy - The Chinese government has implemented a series of regulations to enhance the development of the cosmetics industry, including dermatological skincare products, promoting standardization and high-quality growth [5][6]. Industry Chain - The upstream of the dermatological skincare industry includes suppliers of active ingredients, moisturizers, oils, plant extracts, and production equipment. The downstream consists of hospitals, pharmacies, supermarkets, beauty salons, brand counters, and e-commerce platforms [7][10]. Development Status - The market for dermatological skincare products is experiencing exponential growth, driven by increasing skin issues among consumers and a shift towards scientific skincare. Despite rapid development, the market penetration in China remains low compared to mature overseas markets, indicating significant future growth potential [1][12]. Competitive Landscape - The dermatological skincare market in China is becoming increasingly competitive, with numerous companies entering the space. Key players include Peirfaer (Shanghai) Cosmetics Trading Co., L'Oréal (China) Co., Shenzhen Haichuang Biotechnology Co., and others [14][16]. Representative Company Analysis - Yunnan Betaini Biotechnology Group Co., established in 2010, focuses on skin health and has gained recognition for its "Winona" brand, achieving a revenue of 5.736 billion yuan in 2024, with skincare products accounting for 83.70% of total revenue [16]. - Beijing Andeputai Medical Technology Co., founded in 2010, specializes in solutions for problematic skin and integrates global resources for medical research and product development [18]. Development Trends - The trend of "minimalist skincare" is emerging, with consumers favoring simplified formulations. Additionally, domestic brands are leveraging cross-border e-commerce to expand internationally, supported by capital mergers to enhance global competitiveness [21].

Investment Rating - Industry rating: Recommended [5] Core Insights - The beauty sector experienced a stable conclusion during the 618 shopping festival, with significant changes in platform and brand dynamics driven by reduced commission policies and interest-based content ecosystems [1][2] - The total GMV for beauty products across four major e-commerce platforms (Taobao, JD, Douyin, Kuaishou) during the 618 period was between 600-700 billion yuan, reflecting a year-on-year growth of over 10% [1] - Taobao maintained the largest market share at 41.3%, followed by Douyin at 35.7%, JD at 14.8%, and Kuaishou at 8.2% [1][13] Summary by Sections E-commerce Platform Dynamics - Douyin's beauty segment is rapidly growing, supported by merchant subsidies and interest-driven consumer engagement, achieving double-digit growth [2] - Douyin's promotional strategies included a 1.4 billion yuan subsidy for merchants in May, with individual merchant reductions reaching up to 2.99 million yuan [2] Skincare and Makeup Categories - In the skincare category, domestic brands like Proya and Han Shu led the market, maintaining their top positions on Taobao and Douyin [3] - The top five brands in the skincare category on Taobao remained stable, with Proya and Han Shu continuing to dominate [3] - In the makeup and fragrance category, new domestic brands are emerging, with Ti Luo Wei achieving rapid growth by focusing on base makeup products [4] International and Domestic Brand Strategies - International brands are performing well due to localized marketing strategies and a willingness to engage with local consumers [8] - Domestic brands are expected to break out of the competitive cycle focused on ingredients and efficacy, emphasizing brand influence and comprehensive user experience [8] Investment Recommendations - Focus on domestic companies with strong brand equity and comprehensive channel strategies, particularly Proya and Han Shu [9] - Highlight technology-driven skincare brands like Betaini and Juzi Biology that target specific consumer needs [9] - Consider daily chemical brands with strong cost-performance ratios and excellent management of emerging channels, such as Runben and Dengkang [9]